Ready-to-use stem cell kits for pets coming soon? Gallant closes $18M Series B funding
A US-based startup focused on curing pet health issues with ready-to-use stem cell therapies has secured over $18 million in fresh funding. Founded by Aaron Hirschhorn, Gallant is looking to develop the first off-the-shelf stem cell therapy kits in veterinary medicine that has been approved by the US Food and Drug Administration (FDA). Its latest […]
Continue Reading
